Cargando…

Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat hypercholesterolemia, is associated with a better disease outcome. Whether statins directly affect virus replication or influence the clinical outcome through modulation of immune responses is unknown. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zapatero-Belinchón, Francisco J., Moeller, Rebecca, Lasswitz, Lisa, van Ham, Marco, Becker, Miriam, Brogden, Graham, Rosendal, Ebba, Bi, Wenjie, Carriquí-Madroñal, Belén, Islam, Koushikul, Lenman, Annasara, Gunesch, Antonia P., Kirui, Jared, Pietschmann, Thomas, Överby, Anna K., Jänsch, Lothar, Gerold, Gisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599137/ https://www.ncbi.nlm.nih.gov/pubmed/34812415 http://dx.doi.org/10.1016/j.isci.2021.103469

Ejemplares similares

The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry
por: Kirui, Jared, et al.
Publicado: (2021)

Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity
por: Zapatero-Belinchón, Francisco J., et al.
Publicado: (2021)

The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity
por: Carriquí-Madroñal, Belén, et al.
Publicado: (2023)

The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication
por: Lasswitz, Lisa, et al.
Publicado: (2022)

Cholesterol sensing by CD81 is important for hepatitis C virus entry
por: Palor, Machaela, et al.
Publicado: (2020)

The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection
por: Lindqvist, Richard, et al.
Publicado: (2020)

CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells
por: Banse, Pia, et al.
Publicado: (2018)

Glycomics and Proteomics Approaches to Investigate Early Adenovirus–Host Cell Interactions
por: Lasswitz, Lisa, et al.
Publicado: (2018)

Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
por: Ricke-Hoch, Melanie, et al.
Publicado: (2021)

Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells
por: Alberione, María Pía, et al.
Publicado: (2020)

Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
por: Gerold, Gisa, et al.
Publicado: (2013)

Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections
por: Rosendal, Ebba, et al.
Publicado: (2022)

Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors
por: Zapatero-Belinchón, Francisco J., et al.
Publicado: (2019)

Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB
por: Bruening, Janina, et al.
Publicado: (2018)

Special Issue “Adenovirus Pathogenesis”
por: Arnberg, Niklas, et al.
Publicado: (2021)

Decoding protein networks during virus entry by quantitative proteomics
por: Gerold, Gisa, et al.
Publicado: (2016)

Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)

A multitask transfer learning framework for the prediction of virus-human protein–protein interactions
por: Dong, Thi Ngan, et al.
Publicado: (2021)

The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission
por: Mhlekude, Baxolele, et al.
Publicado: (2021)

Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes
por: Nicolay, Wiebke, et al.
Publicado: (2021)

The Difference in Pharmacokinetics and Pharmacodynamics between Extended-Release Fluvastatin and Immediate-Release Fluvastatin in Healthy Chinese Subjects
por: Xu, H. R., et al.
Publicado: (2012)

Effects of Fluvastatin on the Pharmacokinetics of Repaglinide: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Fluvastatin
por: Lee, Chong-Ki, et al.
Publicado: (2013)

BAF45b Is Required for Efficient Zika Virus Infection of HAP1 Cells
por: Persson, B. David, et al.
Publicado: (2021)

Kinetic Spectrophotometric Determination of Fluvastatin in Pharmaceutical Preparations
por: Ashour, Safwan, et al.
Publicado: (2010)

Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93.
por: Welen, Karin, et al.
Publicado: (2022)

Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin
por: Wuestenberg, Andrea, et al.
Publicado: (2014)

Inhibition of Candida albicans by Fluvastatin Is Dependent on pH
por: Schmidt, Martin, et al.
Publicado: (2009)

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
por: El-Helw, Abdel-Rahim M, et al.
Publicado: (2015)

Fluvastatin protects cochleae from damage by high-level noise
por: Richter, Claus-Peter, et al.
Publicado: (2018)

Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin
por: Li, Jun, et al.
Publicado: (2018)

Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
por: Cheng, Yang, et al.
Publicado: (2017)

Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
por: Yang, Zuozhang, et al.
Publicado: (2017)

Fluvastatin Sodium Ameliorates Obesity through Brown Fat Activation
por: Yin, Na, et al.
Publicado: (2019)

Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw
por: Adachi, Naomi, et al.
Publicado: (2020)

Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
por: Okubo, Kazuki, et al.
Publicado: (2019)

Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2021)

Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2022)

Persistent Infection of a Canine Histiocytic Sarcoma Cell Line with Attenuated Canine Distemper Virus Expressing Vasostatin or Granulocyte-Macrophage Colony-Stimulating Factor
por: Marek, Katarzyna, et al.
Publicado: (2022)

Fluvastatin Influences Hair Color in C57Bl/6 Mice
por: Galus, Ryszard, et al.
Publicado: (2013)

Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury
por: Alanazi, Najah S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b6a57tkoa6psssutev4np3bm8c